I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Keratoconus, is an ectatic, non-inflammatory, bilateral, and asymmetric disorder of the eye. It begins at puberty and stabilizes during the fourth decade.[@ref1] Clinical application in keratoconus requires precise measurements of anterior segment parameters, particularly anterior chamber, which is important in ophthalmology, including preoperative examination and glaucoma management. Anterior chamber depth (ACD) is the distance between the posterior of the cornea and anterior surface of the crystalline lens, and is approximately 3 mm. Age, gender, refractive error, and cataract formation have been reported to affect the ACD.[@ref2] Several studies compared ACD in keratoconic and normal eyes, and results have been reported. Some inconsistency in results and the importance of precise ACD values in clinical decision led us to conduct the review to gain a better understanding of ACD changes in keratoconus patients.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Initially, we searched studies that have evaluated the ACD in keratoconus patients. A comprehensive computer literature search of databases PubMed, Scopus, Ovid, ISI, ScienceDirect, and Google Scholar was conducted to find published articles on this topic. The search algorithm was based on combinations of the following terms: Anterior chamber depth, Anterior segment, and Keratoconus. A beginning date limit was not used, and the search was updated until December 2017 without language restrictions. To identify additional studies and expand our search, the references of the retrieved articles were also screened. Two of the authors (N.Y. and M.K.) independently conducted a systematic search.

Statistical analyses were performed using STATA version 11.0 (College Station, Texas) and RevMan Version 5.3 (Cochrane Collaboration). Mean, standard deviation, and sample size were extracted for both the keratoconus and normal group. Then standardized mean difference was calculated for each study. Standard deviation of the difference was calculated using Cohen approach. Cochran\'s Q-test of heterogeneity was applied to detect the heterogeneity, and between-study heterogeneity was quantified using the I[@ref2] Statistic. According to Higgins grading scale, I[@ref2] value achieving 0.7 or more shows high heterogeneity. Random-effect model was chosen for determining Pooled SMD. Meta-regression method was also applied to evaluate the impact of important factors, age, sample size, publication date, and device on the studies\' heterogeneity. Meta-bias and Eggers test were used to evaluate the publication bias. Meta-funnel principles were used to create a funnel plot. Due to the low power of Eggers test, 0.1 was considered a level of significance. For other tests, 0.05 was the level of the statistical significance.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

[Figure 1](#F1){ref-type="fig"} illustrates the flow of literature reviewed. Our computerized search identified 469 relevant studies. From this, 125 were excluded because of duplication. Two hundred and one studies were excluded after title review. Ninety-seven studies were excluded at the abstract review stage, and 30 studies were excluded at full text screening stage. The final 16 eligible studies were included. One thousand four hundred thirty-five keratoconic eyes and 1334 normal eyes were analyzed.

![Follow diagram of systematic review and meta-analysis](JCO-32-94-g001){#F1}

[Table 1](#T1){ref-type="table"} shows the extracted data of included studies.

###### 

Extracted data

  -----------------------------------------------------------------------------------------------------------------------------------
                                  Age (mean±SD)      Technique                        Normal ACD   Keratoconic ACD        *P*
  ------------------------------- ------------------ -------------------------------- ------------ ---------------------- -----------
  Abolbashari *et al*.[@ref3]     N: 25.44±5.52\     Pentacam                         3.13±0.30    Mild: 3.22±0.24\       0.0001
                                  KCN: 24.27±6.17                                                  Moderate: 3.36±0.20\   
                                                                                                   Severe: 3.65±0.40      

  Kovács *et al*.[@ref4]          N: 39.69±15.77\    Pentacam                         2.83±0.55    3.19±0.28              \<0.001
                                  KCN: 35.25±10.67                                                                        

  Reddy *et al*.[@ref5]           N: 34±10\          Galilei analyzer                 3.30±0.28    3.30±0.21              0.646
                                  KCN: 31±11                                                                              

  Edmonds *et al*.[@ref2]         N: 41.90±12.40\    Pentacam                         3.18±0.28    3.34±0.34              0.003
                                  KCN: 47.5±15                                                                            

  Gispets *et al*.[@ref6]         N: 32.29±8.95\     Pentacam                         3.65±0.33    Stage 1: 3.76±0.48\    --
                                  KCN: 37.46±13.75                                                 Stage 2: 3.68±0.42\    
                                                                                                   Stage 3: 3.86±0.36\    
                                                                                                   Stage 4: 4.09±0.34     

  Fontes *et al*.[@ref7]          N: 35.23±12.60\    Pentacam                         3.05±0.43    3.19±0.35              0.0416
                                  KCN: 34.98±12.40                                                                        

  Emre *et al*.[@ref8]            N: 28.50±8.80\     Pentacam                         3.10±0.30    Mild: 3.20±0.30\       0.0001
                                  KCN: 27.30±9.10                                                  Moderate: 3.30±0.30\   
                                                                                                   Severe: 3.70±0.40      

  Sahebjada *et al*.[@ref1]       N: 40\             Pentacam                         3.10±0.48    Mild: 3.39±0.55\       0.148\
                                  KCN: 34.5                                                        Moderate: 3.31±0.48\   0.883
                                                                                                   Severe: 3.43±0.58      

  Demir *et al*.[@ref9]           N: 26.30±8.30\     Galilei analyzer                 3.31±0.30    3.30±0.29              0.149
                                  KCN: 25.7±6.70                                                                          

  Lim *et al*.[@ref10]            N: 31.60±6.40\     Orbscan II                       3.55±0.29    3.70±0.31              \<0.01
                                  KCN: 29.60±9.20                                                                         

  Aurich *et al*.[@ref11]         N: NA\             Optical coherence tomography     3.1±0.40     3.60±0.40              \<0.05
                                  KCN: 32±7                                                                               

  Mas-Aixala *et al*.[@ref12]     N: 34.14±8.49\     Pentacam                         3.06±0.43    3.34±0.45              0.004
                                  KCN: 35.29±13.21                                                                        

  Montalbán *et al*.[@ref13]      N: 37\             Sirius                           2.96±0.40    3.37±0.36              0.250
                                  KCN: 35                                                                                 

  Huseynova *et al*.[@ref14]      N: 23.19±4.52\     Pentacam                         3.07±0.28    3.26±0.32              \<0.0001
                                  KCN: 23.77±7.67                                                                         

  Uçakhan *et al*.[@ref15]        N: 29.10±8.10\     Pentacam                         3.31±0.34    3.47±0.27              0.019
                                  KCN: 26.10±5.90                                                                         

  Safarzadeh and Nasiri[@ref16]   N: 28.7±7.00\      Scheimpflug-placido topography   3.1±0.20     Suspect: 3.20±0.30\    0.840\
                                  KCN: 26±7.50                                                     Mild: 3.20±0.30\       0.340\
                                                                                                   Moderate: 3.30±0.20\   \<0.0001\
                                                                                                   Severe: 3.60±0.30      0.006
  -----------------------------------------------------------------------------------------------------------------------------------

SD: Standard deviation, ACD: Anterior chamber depth, KCN: Keratoconu, NA: Not available

[Figure 2](#F2){ref-type="fig"} shows the forest plot for Pooled SMD and 95% confidence interval (CI) based on applied device in each study. There was a statistically significant difference between Pooled SMD according to applied device (chi2: 41.23; *P* \< 0.001). As it has been illustrated, Pooled SMD for Pentacam was 0.61 (0.50-0.72), 1.22 (0.52-1.92) for optical coherence tomography, 0.50 (0.28-0.72) for Orbscan, and 1.06 (0.72-1.40) for Sirius. The results showed the significant deeper ACD in keratoconic eyes compared with normal eyes. Pooled SMD for Galilei analyzer did not show the significant difference in ACD between keratoconus and normal groups. (SMD: --0.02; 95% CI: --0.23 to 0.19).
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Considering Q-test results, there was significant heterogeneity between Pooled SMD in each study (chi2: 52.84; *P* \< 0.001). I[@ref2] value of 72% implied considerable heterogeneity. [Table 2](#T2){ref-type="table"} shows the results of meta-regression analysis. After adjusting for the factors of age, sample size, and year of publication, we found that applied device had considerable effect on heterogeneity (b: 0.213; *P* \< 0.001).

###### 

Result of univariate meta-regression analysis to determine heterogeneity determinants of standardized mean difference

  Variable            Coefficient   95% CI         *P*
  ------------------- ------------- -------------- ---------
  Device              0.213         0.122-0.303    \<0.001
  Sample size (eye)   −0.005        −0.002-0.001   0.534
  Year publication    0.003         −0.057-0.065   0.893
  Age mean (years)    −0.025        −0.078-0.027   0.325

Device variable coding - 1: Galilei analyzer, 2: Optical coherence tomography, 3: Orbscan, 4: Pentacam, 5: Sirius. CI: Confidence interval

The result of Egger\'s test indicated that significant bias did not exist between studies (b: 1.78; P: 0.275) \[[Figure 3](#F3){ref-type="fig"}\].
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D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

This article represents a systematic and comprehensive review of published data involving ACD changes in keratoconus. Studies have shown that it is significantly deeper in keratoconus patients than normal controls.[@ref2][@ref4][@ref5] A number of studies evaluated the rate of progression in ACD in different stages of keratoconus and reported that along with progression of the KCN, ACD will be deeper.[@ref1][@ref3][@ref6][@ref8][@ref16] Just in one study by Abolbashari *et al*., ACD was evaluated at center, 1 mm paracentral, and thinnest pachymetry in different stages of the KCN and compared with normal eye and reported a similar result.[@ref3] In contradiction to previous above-mentioned studies, Montalbán *et al*. reported that there is no statistically significant difference in the ACD between keratoconic and normal eyes.[@ref13] The difference in result could be due to the measurement system or the wide age-range of the population. This analysis demonstrates that ACD is one of the most important factors in ocular surgery, and glaucoma management is deeper in keratoconic eyes than normal, which could be due to anterior protrusion of the central. Therefore, accurately measured ACD is essential for preoperative examination and glaucoma management.
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